Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Five Below: Target raised at Oppenheimer on 'outsized sales and EPS expansion'

Published 01/25/2023, 11:22 AM
Updated 01/25/2023, 11:54 AM
© Reuters.  Five Below (FIVE): target raised at Oppenheimer on "outsized sales and EPS expansion"

By Vlad Schepkov 

Oppenheimer analysts reiterated an "Outperform" rating on Five Below (NASDAQ:FIVE) and raised their Price Target on shares to $235 from $165, noting that "stars are aligning" for the company, which they now rank "among favorite mid-cap names within Consumer Growth & eCommerce coverage."

The analysts outline several strong positives FIVE can offer to "growth-oriented investors navigating an uncertain consumer backdrop":

1. The company's "Triple Double" strategy of doubling sales and EPS by FY25 remains intact: "Management indicates clearly that while unexpected, pandemic-related disruptions impacted trends in 1H22, underlying progress toward the Triple Double plan is intact, with realization of goals likely only modestly delayed."

2. Continuous rollout of "Five Beyond" stores, seen as "incremental comp driver": "250 store conversions completed in 2022 and an estimated 400 set for 2023. Per our math, Five Beyond conversions should lift total company comps 60-110 bps in 2023."

3. Opportunities for potential market share gains: "ongoing struggles at now bankrupt Party City could ultimately make for an incremental market share opportunity of upward of $800M in select party-related categories for FIVE."

4. Compelling valuation at current price levels: "12- to 18-month price target of $235 is predicated upon a mid-20s multiple applied to our newly established FY25 (Jan. 2026) EPS forecast of $9.31, a level that represents a conservatively healthy discount to current trading parameters for shares and reflects continued compelling and outsized growth prospects for FIVE."

On the sum of factors, the analysts believe "FIVE continues to successfully build out its base of stores, increasingly capitalizing on the woes of less well-positioned operator," and are "optimistic that the growth premium currently afforded shares will sustain given outsized sales and EPS expansion."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Oppenheimer reiterates an "Outperform" rating on the stock and raises Price Target to $235.

Shares of FIVE are currently trading around $190, and are up over 10% YTD.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.